SCHEMBL26065145

SCHEMBL26065145

CC(C)(C)OC(=O)N1CCN(CC2CCOCC2)CC1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
USP2 O75604 1/20 0.58
SMN1; SMN2 Q16637 1/20 0.58
RECQL P46063 1/20 0.55
CNR1 P21554 1/20 0.44
HPGD P15428 1/20 0.43
ALDH1A1 P00352 3/20 0.42
GPR119 Q8TDV5 2/20 0.42
EPHX1 P07099 1/20 0.42
MAPT P10636 2/20 0.41
CHRM2 P08172 1/20 0.41
CHRM4 P08173 1/20 0.41
CHRM1 P11229 1/20 0.41
CHRM3 P20309 1/20 0.41
NPC1 O15118 1/20 0.41
MAPK1 P28482 1/20 0.41
HTT P42858 1/20 0.41
RAB9A P51151 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
NR1H2 P55055 1/20 0.41
LMNA P02545 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1100404 0.90 CNR1 (0.51) USP2SMN1; SMN2RECQLCNR1HPGD
SCHEMBL20873836 0.90 CNR1 (0.51) USP2SMN1; SMN2RECQLCNR1HPGD
SCHEMBL1088712 0.89 USP2 (0.62) USP2SMN1; SMN2RECQLHPGDGPR119
SCHEMBL20873854 0.88 HPGD (0.51) USP2SMN1; SMN2RECQLCNR1HPGD
SCHEMBL1307642 0.87 EPHX1 (0.51) USP2SMN1; SMN2RECQLCNR1HPGD
SCHEMBL2732005 0.87 HPGD (0.50) USP2SMN1; SMN2RECQLCNR1HPGD
SCHEMBL5573169 0.86 HPGD (0.53) USP2SMN1; SMN2RECQLCNR1HPGD
SCHEMBL1969568 0.85 EPHX1 (0.54) USP2SMN1; SMN2RECQLCNR1HPGD
SCHEMBL24764173 0.84 CNR1 (0.47) USP2SMN1; SMN2RECQLCNR1HPGD
SCHEMBL29928185 0.84 NR1H2 (0.56) USP2SMN1; SMN2RECQLCNR1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023164063-A1 EMOPAMIL-BINDING PROTEIN INHIBITORS AND USES THEREOF BIOGEN MA INC. (US) 2023-08-31 WO disclosed